ABVC BioPharma Inc. (ABVC)

AI Score

Unlock

0.74

-0.17 (-19.08%)

At close: Apr 04, 2025, 3:59 PM

0.82

11.05%

After-hours: Apr 04, 2025, 05:19 PM EDT

ABVC BioPharma Cash Flow Statement

Chart Mode

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009	FY 2008	FY 2007	FY 2006	FY 2005	FY 2004	FY 2003	FY 2002
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Sep 30, 2016	Sep 30, 2015	Sep 30, 2014	Sep 30, 2013	Sep 30, 2012	Dec 15, 2011	Sep 30, 2010	Sep 30, 2009	Sep 30, 2008	Sep 30, 2007	Dec 31, 2006	Dec 31, 2005	Dec 31, 2004	Dec 31, 2003	Dec 31, 2002
Net Income	-10.52M	-16.31M	-12.04M	-10.59M	-3.93M	-4.1M	-6.67M	-4.51M	-32.28K	-70	-226.35K	-1.07M	-1.22M	-1.9M	-5.18M	-6.77M	-4.65M	-25.4K	-16.36K	2.54K	-25.36K	-20K
Depreciation & Amortization	28.53K	23.8K	11.99K	37.14K	55.09K	43.61K	44K	n/a	n/a	n/a	23.86K	33.05K	34.18K	45.25K	45.08K	37.49K	12.76K	n/a	n/a	n/a	n/a	n/a
Stock-Based Compensation	1.64M	7.04M	5.31M	4.15M	22.31K	28.8K	155.4K	1.3M	30K	n/a	n/a	196.12K	730.24K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Working Capital	748.4K	1.22M	-1.44M	-1.01K	666.86K	794.55K	840.43K	-280.6K	5.12K	n/a	84.04K	335K	131.01K	175.62K	165.09K	n/a	n/a	n/a	n/a	-7.86K	7.96K	-40K
Other Non-Cash Items	3.52M	353.04K	-91.05K	2.16M	204.34K	2.55M	4.32M	-5.18M	-23.04K	n/a	n/a	-217.55K	-1.98M	671.92K	3.5M	3.25M	1.96M	n/a	-1.32K	n/a	-15.18K	50K
Deferred Income Tax	115.67K	864.8K	824.2K	-223.2K	-80.69K	-366.95K	-360.39K	n/a	n/a	n/a	n/a	n/a	1.22M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	976.96K	635.57K	-1.61M	-86.43K	597.67K	892.31K	824.81K	-262.23K	5.64K	1.24K	164.72K	142.84K	-380.59K	136.66K	77.82K	1.14M	-14.74K	49.85K	-742	-9.98K	40.9K	-40K
Operating Cash Flow	-4.24M	-7.4M	-7.6M	-4.56M	-3.13M	-630.2K	-1.68M	-3.47M	3.36K	1.17K	-37.77K	-915.12K	-1.59M	-1.05M	-1.56M	-2.34M	-2.69M	24.45K	-18.43K	-7.45K	355.00	-10K
Capital Expenditures	-21.2K	-119.69K	-17.5K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-19.55K	-41.74K	-11.37K	-59.44K	-215.94K	-97.56K	n/a	n/a	n/a	n/a	n/a
Acquisitions	-338.99K	-1.6M	-680.92K	n/a	-17.8K	n/a	-7.8M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	-1.6M	-107.55K	n/a	-17.8K	-156.37K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	3.2M	788.46K	147.8K	n/a	n/a	128.48K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	-1.6M	-788.46K	-373.24K	305.00	-156.37K	180.91K	n/a	n/a	n/a	n/a	n/a	3K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	-360.19K	-1.72M	-805.97K	-225.43K	-35.3K	-156.37K	-7.49M	n/a	n/a	n/a	n/a	-19.55K	-38.74K	-11.37K	-59.44K	-215.94K	-97.56K	n/a	n/a	n/a	n/a	n/a
Debt Repayment	462.62K	350K	-177.74K	1.95M	2M	593K	3.58M	n/a	n/a	n/a	25K	221.27K	55.9K	570.42K	-297.38K	708K	378.83K	n/a	n/a	-4.54K	-12.04K	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	30K
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	2.41M	n/a	-946.16K	n/a	552.96K	n/a	-2.02M	303.41K	n/a	n/a	n/a	604.33K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-10.95K	10.95K	10K
Financial Cash Flow	3.92M	4.01M	10M	9.57M	3.09M	593K	9.33M	2.65M	995.54K	-1.79K	25K	876.27K	1.7M	1.06M	641.12K	2.72M	2.86M	n/a	n/a	-15.49K	103.21K	10K
Net Cash Flow	-674.95K	-5.17M	1.56M	4.84M	-82.34K	-37.2K	156.46K	-821.29K	998.9K	-618	-12.77K	-58.4K	68.97K	2.81K	-974.28K	166.11K	71.78K	24.45K	-18.43K	-22.94K	103.56K	n/a
Free Cash Flow	-4.26M	-7.52M	-7.62M	-4.56M	-3.13M	-630.2K	-1.68M	-3.47M	3.36K	1.17K	-37.77K	-934.67K	-1.63M	-1.06M	-1.62M	-2.55M	-2.79M	24.45K	-18.43K	-7.45K	355.00	-10K